Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced NIGHTINGALE ...

The Slayer's new game is being dubbed as "woke" by some online because it gives players the option to customize their ...

They got the match-up they were wanting. On Sunday, the Canadian men’s soccer team will face the United States in the ...

MGUS is not considered cancer, but some people with MGUS will eventually develop a cancer such as multiple myeloma or lymphoma. They might also develop amyloidosis, a condition linked with blood ...